Bosutinib is a small molecule bcr-abl and src tyrosine kinase inhibitor used for the treatment of chronic myelogenous leukemia. Originally synthesized by wyeth, it is being developed by pfizer bosutinib is a small molecule bcr-abl and src tyrosine kinase inhibitor used for the treatment of chronic myelogenous leukemia. Originally synthesized by wyeth, it is being developed by pfizer
Member Since 5 Years
Nature of Business Distributor
For Buyer 
For Seller 
Help 
Allalasandra, Bangalore, Karnataka 
Send Enquiry